2/ IP Tokens are coming to Bio V2. Each represents a single unit of science (compound, screen, or method) with built-in funding and governance. Launching via Ignition Sales for $BIO & BioXP holders, with value cycling back to BioAgents and BioDAOs. https://docs.bio.xyz/bio/intro...

3/ Vibe Science session: Aubrey de Grey and @vita_dao researchers used the @Aubrai_ Terminal for live hypothesis building, experiment design, RMR2 study updates, and proof of invention minting. https://x.com/i/broadcasts/1Od...

4/ Longevity Hypothesis Challenge: Researchers using @Aubrai_ to develop hypotheses can qualify for up to $100K in funding. Referrals earn a 20K $BIO bounty if the proposal is selected by Aubrey de Grey.

5/ BioXP update: New yapping XP drop covering Aug 25–Sept 3. BioXP distributions are moving to every 3–7 days, with weighting toward quality contributions and BIO ecosystem staking.

6/ VitaDAO proposed $50K to fund the design of an RNA therapeutic targeting FOXO3, a key longevity gene linked to tissue repair and health span.

7/BioAgents roadmap: Improved citation accuracy, multi-source hypothesis generation, and open benchmarking in progress. Work underway on multiplayer BioAgent marketplaces with agent-to-agent payments.

8/ Ecosystem updates: → @vita_dao-backed Remedium Bio partnered with Eli Lilly on gene therapy R&D. → @valley_dao funding carbon-negative biomaterials for Tattva, → @pumpdotscience reached $13M in trading volume and enabled 77 longevity experiments since launch with upcoming

9/ Community highlights: → @CerebrumDao launched a discount for Percepta, a brain health supplement to support decentralized brain health trials. → @HairDAO_ set a lab record in follicle protein staining. →Prima Donna supported by @Molecule_dao launched enamel regrowth IP

10/ → @psy_dao partnered with INME to fund psilocybin research. → @endrarediseases backed RAPTOR raised $45K from trading fees to support their animal studies.

11/ →DeSci Boston at MIT brought projects together, while the Bio Asia Tour continues with summits and meetups. →Bio Protocol is hosting a intimate DeSci dinner on September 16th in Cambridge during Boston Biotech week.

12/ Bio & VitaDAO are looking for AI team members with a strong research background, experience building with AI and & product-oriented full stack devs.

13/ That concludes last week across Bio: IP Tokens, Vibe Science, FOXO3 funding, $100K challenges, BioAgents progress, and DeSci collaborations worldwide. Read the full weekly report👇

@BioProtocolEco FOXO3 funding is the kind of moonshot aging research needs

@BioProtocolEco FOXO3 RNA play could be a sleeper hit in the whole longevity race

@BioProtocolEco DeSci speedrunning science

@BioProtocolEco FOXO3 funding is huge, that gene is a real longevity lever

@BioProtocolEco The pace of Bio x DeSci right now feels like early internet energy small moves, huge ripples

@BioProtocolEco Bio + DeSci is heating up fast

@BioProtocolEco FOXO3 funding is a big deal longevity biotech just leveled up

@BioProtocolEco IP tokens + $100K = a new playbook for rapid validation who’s building modular assays?

@BioProtocolEco FOXO3 funding is a big signal longevity biotech is entering execution mode

@BioProtocolEco FOXO3 RNA therapeutic move is huge, wonder how fast that gets from proposal to preclinical

@BioProtocolEco how will FOXO3 funding speed real trials?

@BioProtocolEco FOXO3 RNA work could redefine the playbook for human healthspan

@BioProtocolEco great recap how will ip token ignition align funding with reproducible open research in bio v2?

@BioProtocolEco FOXO3 play is wild… but those enamel regrowth IP tokens might be the real sleeper here

@BioProtocolEco FOXO3 RNA play is stealth longevity alpha

@BioProtocolEco this lineup is pure DeSci acceleration

@BioProtocolEco FOXO3 move is lowkey massive

@BioProtocolEco DeSci needs IRB + regulatory playbooks Who’s building the templates

@BioProtocolEco hey @Aubrai_ tell me what is FOXO3 Gene?

@BioProtocolEco FOXO3 funding could be a gamechanger

@BioProtocolEco curious how Ignition handles overlapping claims on the same compound on-chain arbitration or pre-mint curation?

@BioProtocolEco bio is alive

@BioProtocolEco FOXO3 FUNDING SPARKS NEW R&D

@BioProtocolEco FOXO3 gene play might be the quiet game changer in this whole recap